Skip to content

A study to assess the effectiveness of Lycopodium Clavatum in the homoeopathic management of Functional Dyspepsia among adults

Effectiveness of Lycopodium Clavatum in the homoeopathic management of Functional Dyspepsia among adults : A non-controlled experimental study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112024
Enrollment
40
Registered
2026-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

Intervention1: Homoeopathic Management: Homoeopathic remedy Lycopodium Clavatum will be administered orally in globule form as per Homoeopathic principles in appropriate potency i.e potencies above 3c

Sponsors

Dr. G.D. Pol Foundation, Y.M.T. Homoeopathic Medical College, Hospital and P.G. Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Functional Dyspepsia of adult age group from 18- 50 years. Patients of Functional Dyspepsia of all genders. Patient presenting with symptoms suggestive of Functional Dyspepsia. Patients not taking any other medications since 1 week before the treatment. Patient willing to participate and give informed consent. Clinically pre diagnosed patients of Functional Dyspepsia.

Exclusion criteria

Exclusion criteria: Patient with alarm symptoms such as unintentional weight loss, persistent vomiting, dysphagia, GI bleeding, anemia, lymphadenopathy. Patients with known diagnosed conditions like peptic ulcer disease, GERD with complications, gastric malignancy, Chronic Liver Disease. Patients with severe systemic illness like Diabetes with complications, renal failure, cardiac diseases. Patients taking any other medications since 1 week before the treatment. Suspected Immunocompromised patients. Pregnant and Lactating females.

Design outcomes

Primary

MeasureTime frame
Short Form Nepean Dyspepsia IndexTimepoint: At baseline, 3 months and 6 months

Secondary

MeasureTime frame
NATimepoint: NA

Countries

India

Contacts

Public ContactDr Chintan Mehta

Dr. G.D. Pol Foundation, Y.M.T. Homoeopathic Medical College, Hospital and P.G. Institute

omcvm@yahoo.co.in9869021226

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026